Bruker (BRKR) EBT Growth (1y) (2011 - 2026)
Powered by 
Analysis
Bruker (BRKR) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | 12.58% |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | 64.58% |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | 21.31% |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | -15.03% |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | -7.46% |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | 409.20% |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | 30.94% |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | -22.30% |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | -950.00% |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | -150.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -950.00% |
| Mar 31, 2026 | -9.94% |
| Dec 31, 2025 | 26.05% |
| Sep 30, 2025 | -229.84% |
| Jun 30, 2025 | 175.95% |
| Mar 31, 2025 | 132.70% |
| Dec 31, 2024 | 27.15% |
| Sep 30, 2024 | -53.61% |
| Jun 30, 2024 | -113.57% |
| Mar 31, 2024 | -167.48% |
| Dec 31, 2023 | 79.37% |
| Sep 30, 2023 | -7.81% |
| Jun 30, 2023 | 16.63% |
| Mar 31, 2023 | 24.80% |
| Dec 31, 2022 | -0.44% |
| Sep 30, 2022 | 18.84% |
| Jun 30, 2022 | 185.01% |
| Mar 31, 2022 | 207.44% |
| Dec 31, 2021 | -1.39% |
| Sep 30, 2021 | 44.49% |